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Highlights
• A model with environmental, contagious, and a new opportunistic trans-
mission mode
• Two strains of the same pathogen with different transmission modes are
possible
• The model is sensitive to certain parameter changes, proper parameters
are necessary
• Can be used for modelling short and long term decisions for mastitis con-
trol
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A strain-, cow-, and herd-specific bio-economic
simulation model of intramammary infections in dairy
cattle herds
Maya Gussmanna,∗, Carsten Kirkebya, Kaare Græsbølla, Michael Farreb, Tariq
Halasaa
aNational Veterinary Institute, Technical University of Denmark, Kemitorvet, Building 204,
DK-2800 Kgs. Lyngby, Denmark
bSEGES Livestock Innovation, Agro Food Park 15, 8200 Aarhus N. Denmark.
Abstract
Intramammary infections (IMI) in dairy cattle lead to economic losses for farm-
ers, both through reduced milk production and disease control measures. We
present the first strain-, cow- and herd-specific bio-economic simulation model
of intramammary infections in a dairy cattle herd. The model can be used to
investigate the cost-effectiveness of different prevention and control strategies
against IMI. The objective of this study was to describe a transmission frame-
work, which simulates spread of IMI causing pathogens through different trans-
mission modes. These include the traditional contagious and environmental
spread and a new opportunistic transmission mode. In addition, the within-
herd transmission dynamics of IMI causing pathogens were studied. Sensitivity
analysis was conducted to investigate the influence of input parameters on model
predictions. The results show that the model is able to represent various within-
herd levels of IMI prevalence, depending on the simulated pathogens and their
parameter settings. The parameters can be adjusted to include different com-
binations of IMI causing pathogens at different prevalence levels, representing
herd-specific situations. The model is most sensitive to varying the transmission
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rate parameters and the strain-specific recovery rates from IMI. It can be used
for investigating both short term operational and long term strategic decisions
for the prevention and control of IMI in dairy cattle herds.
Keywords: mastitis, mathematical model, cow-specific, pathogen-specific
1. Introduction1
Mastitis or intramammary infection (IMI) is one of the most frequent and2
costly diseases in dairy herds, where costs arise from both milk loss and control3
measures (Seegers et al., 2003; Halasa et al., 2007). They can be caused by4
many different pathogens, traditionally differentiated into environmental and5
contagious. Contagious pathogens are thought to be transmitted during the6
milking process (Harmon, 1994). They can cause outbreaks, infecting many7
animals in a short period of time resulting in high incidence rates (Zadoks et al.,8
2001a). In contrast, environmental pathogens are considered to be transmitted,9
among other things, through reservoirs in the stable and to have an endemic10
nature, associated with low incidence rates (Zadoks et al., 2001a; Blowey and11
Edmondson, 2010).12
Traditionally, Staphylococcus aureus and Streptococcus agalactiae are exam-13
ples for contagious pathogens, while Escherichia coli and Streptococcus uberis14
are considered as environmental. However, Zadoks et al. (2001a) described15
how S. uberis caused an outbreak like situation, suggesting that this particular16
pathogen strain was transmitted contagiously, indicating that different strains17
can have different properties. Consequently, control strategies should take the18
differences (in spread and recovery following treatment) between strains of the19
same pathogen species into account to be effective. Moreover, some pathogen20
strains may create reservoirs in the environment and yet express contagious21
transmission between cows, reflecting an “opportunistic” behavior that combines22
both contagious and environmental characteristics (Jorgensen et al., 2016). In23
order to capture this more differentiated behavior, we introduce a new transmis-24
sion mode with both contagious and environmental characteristics at the same25
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time, in contrast to a purely contagious or purely environmental transmission.26
In the model S. agalactiae is used as an example for the opportunistic nature27
of IMI causing pathogens.28
Simulation models of IMI have previously been used to investigate the im-29
pact of different management strategies against IMI (e.g. Allore et al., 1998;30
Halasa et al., 2010; Hagnestam-Nielsen and Østergaard, 2009; Østergaard et al.,31
2005; Steeneveld et al., 2011; van den Borne et al., 2010a). Some of these mod-32
els have been pathogen-specific, taking traditional transmission modes between33
pathogens into account (Halasa et al., 2009a, 2010). Others were cow-specific,34
taking risk factors for infection into account (Allore et al., 1998), or focusing35
on characteristics of the single cow (Steeneveld et al., 2011); or herd-specific,36
looking into differences between herds such as herds having different pathogens37
(Østergaard et al., 2005). However, to our knowledge, no previous models have38
been simultaneously strain-, cow- and herd-specific. The model we propose39
considers the spread dynamics not only on species level, but also specifically40
distinguishes between different strains of the same species, for instance allowing41
future economic assessment of strain-specific diagnostics, perhaps on farm level.42
It includes the characteristics of the single cow for infection, recovery following43
potential treatment, and its future production potential, allowing a compari-44
son of a cow to its herd mates, while modelling IMI transmission on quarter45
level. This allows investigating cost-effectiveness of control actions on quarter46
level, such as blinding (drying off) chronically infected quarters. In addition,47
the model includes differences between herds such as size, production and man-48
agement. It is thus strain-, cow- and herd-specific and can be used as a tool49
to examine both short and long term decisions to prevent and control IMI for50
individual cows in individual herds, which is to our knowledge not available in51
previous bio-economic models.52
The objective of this study is to describe a new transmission framework of53
IMI causing pathogens, including a new opportunistic transmission mode.54
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2. Materials and methods55
2.1. Model framework56
This study was conducted with the MiCull model (Mastitis-iCull), version57
1.0. The model framework was created by combining an extension of the trans-58
mission framework for IMI created by Halasa et al. (2009a) with the iCull simu-59
lation model of a dairy herd described by Kirkeby et al. (2016), using R version60
3.2.2 – “Fire Safety” (R Core Team, 2015).61
The base iCull model is a stochastic mechanistic bio-economic model that62
simulates a dairy herd using single-day time steps to allow for both operational63
and strategic decision making (Kirkeby et al., 2016). In brief, the model sim-64
ulates a dairy cattle herd in five different physical herd compartments: calves,65
heifers, lactating cows, dry cows and calving area. Each cow spends a random66
(drawn from a given distribution) predefined number of days in each compart-67
ment before moving on to the next, with the exception of possible removal from68
the herd by culling or slaughter decisions (see 2.3). Lactation curves and somatic69
cell count (SCC) curves are modelled for every cow and depend on cow-specific70
parameters, indicating the individual level relative to the mean in the herd71
(Græsbøll et al., 2016). Feeding is dependent on the life stage of each animal,72
and for lactating cows it is modelled based on the amount of milk produced73
(Kirkeby et al., 2016).74
In the present MiCull model, lactation and SCC curves, as well as farmer75
decisions, were adjusted to include IMI related factors as described below.76
The transmission framework for IMI includes environmental (constant infection77
probability), contagious (infection probability depends on the number of infected78
quarters), and opportunistic (infection probability depends on the number of in-79
fected quarters or the presence of bacteria in the environment) transmission on80
quarter level, cow-specific infection and recovery, and different strains of the81
same pathogen.82
5
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
2.2. Pathogen transmission83
Pathogen transmission occurs on quarter level, i.e. between the quarters84
of dairy cows in a herd, independent of whether two quarters belong to the85
same or different cows. Each quarter can be in one of three infection states,86
susceptible (S), subclinically infected (Is), and clinically infected (Ic), or it can87
be blinded (NA). At the moment, the model includes 5 different pathogen strains88
for demonstration purposes (Table 1). Other pathogens or updated pathogen89
parameters can be easily added. New infections with IMI causing pathogens are90
handled differently for milking cows, dry cows and heifers as described below.91
2.2.1. Susceptibility92
The MiCull model is cow-specific, including in the infection process in lac-93
tating cows. Risk factors, such as parity and previous cases of clinical IMI94
(quarter-level), are used to adjust the susceptibility for IMI of a cow (Zadoks95
et al., 2001b). Cows in their first parity and quarters without prior IMI are96
taken as reference, and the risk ratios for cows in the second and third or higher97
parity (RR(parity)), as well as for quarters with prior infections (RR(prior)) are98
calculated (mean of S. aureus and S. uberis, Zadoks et al., 2001b). The product99
of all risk ratios pertaining to a quarter q is then used to adjust the suscepti-100
bility Suscq of the quarter for new IMI, Suscq = RR(parity)q · RR(prior)q . In101
equation (1), the susceptibility leads to an adjustment of the transmission rate,102
depending on cow parameters, thus leading to cow-specific infection.103
2.2.2. Lactating cows104
For lactating cows, all transitions between the three infection states are105
modelled (Figure 1). The probability of infection for each quarter includes the106
susceptibility and is thus cow-specific.107
In the model, all pathogen strains are identified by a unique strain ID108
(strain), and active pathogens are marked as such. Infections can occur for109
all active strains, and the respective infection probabilities p(strain)q are calcu-110
lated for all quarters q every day/time step, depending on the transmission111
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Figure 1: Diagram of the transmission framework used in the simulation model.
mode, see equation (1). In the equation, all parameters except the susceptibil-112
ity factor Suscq (see 2.2.1) and the total number of quarters N depend on the113
pathogen strain, which is not specifically notated in (1) for easier readability, it114
will however be noted in the text (e.g., β(strain) instead of β).115
p(strain)q =

1− exp(−β · Suscq) (environmental),
1− exp (−β · IN · Suscq) (contagious),
1− exp
−β · (1−ε)·I+ε·η·
(∑d
i=1
0.01i·d−1 ·Ii∑d
i=1
0.01i·d−1
+θ
)
N · Suscq
 (opportunistic).
(1)
β(strain) is the transmission rate of that pathogen strain. For environmental116
strains, the infection probabilities only depend on the respective transmission117
rates. I(strain) = I(strain)S + I
(strain)
C (see Figure 1) is the number of quar-118
ters (in lactating cows) already infected with a specific pathogen strain at the119
beginning of the current time step t0. A higher number of infected quarters120
I(strain), increases the infection probability for contagious and opportunistic121
strains. I(strain)i is the number of quarters that were infected with a strain122
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at the end of time step t0 − i. It is taken into account in the environmental123
part of opportunistic transmission, where the pathogen strain decays in the en-124
vironment for d(strain) days until 1% of the initial bacteria remain and then125
disappear. The environmental share is given by ε(strain), while η(strain) is an126
additional scaling factor for the infectiousness of the strain’s environmental part127
compared to its contagious part. θ(strain), representing a purely environmental128
factor (e.g., introduction by humans), allows (re)infection with a strain that is129
not present in the cows nor the environment of the herd. All parameter values130
can be found in Table 1.131
The probabilities p(strain)q of the active pathogens are combined by132
p(total)q = 1−
∏
(1− p(strain)q ), (2)
and each previously uninfected quarter gets infected with this probability. The133
infecting pathogens are then drawn according to their relative risk. Infected134
quarters are allocated to I(strain)S or I
(strain)
C depending on the probability135
P
(strain)
c (Table 1).136
At each new time step, previously subclinically infected quarters in IS have137
the chance to flare up or spontaneously recover (Figure 1) with a certain pathogen-138
specific probability (Table 1). The clinically infected quarters are subjected to139
a three day treatment (default) with antibiotics, they will thereafter either re-140
cover or persist as subclinical cases (remission) (Figure 1). The probability for141
recovery depends on the causative pathogen and is cow-specific, according to142
Steeneveld et al. (2011) (Table 1 shows the base probability).143
The model includes the possibility to scale transmission rate, flare up prob-144
ability, and spontaneous recovery probability by any factor, and to replace the145
probability P (pathogen)c that a new infection will be clinical by another value.146
2.2.3. Dry cows147
For dry cows, IMI will generally be or stay subclinical, except in the first or148
last week of the dry period, where clinical IMI can also occur.149
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Transmission rate (β)
Rate for susceptible animals
entering subclinical or clinical
state
S. aureus 0.0179* Zadoks et al. (2002)
S. agalactiae 0.0068 Leelahapongsathon et al. (2016)
S. uberis (contagious) 0.0155* Zadoks et al. (2001a)
S. uberis (environmental) 0.0155* Zadoks et al. (2001a)
E. coli 0.0001* Barkema et al. (1998)
Probability of clinical
state (Pc)
Probability of entering clinical
state when infected
S. aureus 0.17 Swinkels et al. (2005a)
S. agalactiae 0.01* **
S. uberis (contagious) 0.32 Zadoks et al. (2003)
S. uberis (environmental) 0.32 Zadoks et al. (2003)
E. coli 0.85 Hogan and Smith (2003)
Flare up probability
Probability of subclinical
animals going to clinical state
S. aureus 0.0081* winkels et al. (2005a)
S. agalactiae 0.0005* **
S. uberis (contagious) 0.0068* Swinkels et al. (2005b)
S. uberis (environmental) 0.0068* Swinkels et al. (2005b)
E. coli 0.0035* Do¨pfer et al. (1999)
Spontaneous recovery
probability
Base probability of spontaneous
cure for subclinical animals
S. aureus 0.0064* van den Borne et al. (2010b)
S. agalactiae 0.0023* Leelahapongsathon et al. (2016)
S. uberis (contagious) 0.0143* van den Borne et al. (2010b)
S. uberis (environmental) 0.0143* van den Borne et al. (2010b)
E. coli 0.0221* van den Borne et al. (2010b)
Recovery probability
Probability of recovery for
clinical animals that are treated
S. aureus 0.4 Steeneveld et al. (2011)
S. agalactiae 0.7 Steeneveld et al. (2011)***
S. uberis (contagious) 0.7 Steeneveld et al. (2011)
S. uberis (environmental) 0.7 Steeneveld et al. (2011)
E. coli 0.8 Steeneveld et al. (2011)
ε Environmental share in oppor-
tunistic transmission
S. agalactiae 0.1 arbitrary
η Scaling factor for infectiousness
of environmental part in oppor-
tunistic transmission
S. agalactiae 1 arbitrary
θ Purely environmental factor in
opportunistic transmission
S. agalactiae 0 arbitrary
d Number of days the bacteria sur-
vive in the environment
S. agalactiae 40 arbitrary, more than four weeks
(Jorgensen et al., 2016)
* rounded values
** S. aureus values were adjusted by the factor by which incidence is different in Barkema et al. (1998).
*** used value of Streptococcus dysgalactiae or uberis
Table 1: Rates and probabilities used in the transmission framework for lactating cows (Figure 1). All parameters are implemented in daily time
steps, for all quarters.
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New infections in dry cows can occur for every active strain. Contagious150
strains are considered active, if at least one quarter of one cow in the herd is151
infected with that particular strain. Similarly, opportunistic strains are con-152
sidered active, if they are still present in the herd or if they have a non-zero153
purely environmental element θ(strain). This is important, as the probability of154
infection is calculated according to155
p(strain) = 1− exp
(
−β(dct,strain)dry
)
(3)
for every active pathogen strain, where β(dry,strain)dry is depending on both the156
pathogen and whether the cow was treated with dry cow therapy or not (Table157
2). Note that the infection probability in the dry period is the same for all158
quarters and not cow-specific. The probabilities of the active pathogens are159
combined by (2). Each previously uninfected quarter gets infected with this160
probability. The infecting pathogens are then drawn according to their relative161
risk. Infected quarters are allocated to I(strain)S or, if the cow is in the first or162
last week of the dry period, to I(strain)S or I
(strain)
C depending on the probability163
P
(strain)
c,dry (Table 2).164
Similar to lactating cows, subclinically infected quarters in dry cows can165
flare up or spontaneously recover (Table 2), however flare up can only happen166
in the first or last week of the dry period.167
Additionally, a cow with a flared up quarter in the first week after dry off will168
receive dry cow treatment. Dry cow quarters change their status from IC to IS169
or S after the same number of days as for clinical cases in lactating cows. Here,170
dry cow treatment influences the probability of recovery for the clinical quarter171
(Table 2). For clinical quarters in the last week of the dry period, the probability172
for recovery is calculated similarly as for lactating cows, only without regarding173
somatic cell count (SCC) and days in milk.174
As for lactating cows, transmission rate, flare up probability, and sponta-175
neous recovery probability can be scaled and the probability P (strain)c,dry that a176
new infection will be clinical can be replaced.177
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Parameter Description Pathogen Value Reference
Transmission rate
(βdry)
Rate for susceptible animals
entering subclinical or clinical
state
S. aureus 0.0179* **
S. agalactiae 0.0011* ***
S. uberis (contagious) 0.0011* Halasa et al. (2010, 2009c)
S. uberis (environmental) 0.0011* Halasa et al. (2010, 2009c)
E. coli 0.0001* **
Transmission rate
(β(dct)
dry
)
Rate for susceptible animals
with dry cow treatment entering
subclinical or clinical state
S. aureus 0.0005* Halasa et al. (2010, 2009c)
S. agalactiae 0.0003* ***
S. uberis (contagious) 0.0003* Halasa et al. (2010, 2009c)
S. uberis (environmental) 0.0003* Halasa et al. (2010, 2009c)
E. coli 0.0001* **
Probability of clinical
state (Pc)
Probability of entering clinical
state when infected
S. aureus 0.1 Halasa et al. (2010)
S. agalactiae 0.1 ***
S. uberis (contagious) 0.1 Halasa et al. (2010)
S. uberis (environmental) 0.1 Halasa et al. (2010)
E. coli 0.1 Halasa et al. (2010)
Flare up probability
Probability of subclinical
animals going to clinical state
S. aureus 0.006* Halasa et al. (2010)
S. agalactiae 0.0005* **
S. uberis (contagious) 0.004* Halasa et al. (2010)
S. uberis (environmental) 0.004* Halasa et al. (2010)
E. coli 0.0035* **
Spontaneous recovery
probability
Probability of spontaneous cure
for subclinical animals
S. aureus 0.0079* Halasa et al. (2010)
S. agalactiae 0.0086* ***
S. uberis (contagious) 0.0086* Halasa et al. (2010)
S. uberis (environmental) 0.0086* Halasa et al. (2010)
E. coli 0.0221* **
Recovery probability
Probability of recovery for
clinical animals with dry cow
treatment
S. aureus 0.77 Halasa et al. (2010, 2009b)
S. agalactiae 0.89 ***
S. uberis (contagious) 0.89 Halasa et al. (2010, 2009b)
S. uberis (environmental) 0.89 Halasa et al. (2010, 2009b)
E. coli 0.9 Halasa et al. (2010, 2009b)
* rounded values
** same value as during lactation
*** value of Streptococcus spp.
Table 2: Rates and probabilities used in the transmission framework for dry cows (Figure 1), probability of clinical state, flare up and spontaneous
recovery were taken from Halasa et al. (2010), who recalculated them from Bradley and Green (2004) and Green et al. (2005). All parameters are
implemented in daily time steps, for all quarters.
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2.2.4. Heifers178
Currently, there is no dynamic pathogen transmission in heifers, i.e. cows179
prior to their first calving. Instead, each pathogen strain has a certain proba-180
bility to infect heifers (Table 2). These probabilities are added up for the active181
pathogens to a total probability for heifers to be assigned to IS one day before182
calving. The pathogens are then drawn depending on their part of the total183
probability.184
2.3. Production effects and economy185
2.3.1. Feeding186
Cows are often fed roughage as basic feed plus concentrate to facilitate a187
higher milk production. To our knowledge, no studies have explicitly estimated188
the decrease in feed due to IMI. In this model, the feed usage per lactating189
cow is a function of the energy-corrected milk (ECM) produced, corresponding190
to €0.1852 per ECM (following Kirkeby et al., 2016). Therefore, cows with191
subclinical and clinical IMI automatically have a decreased feed intake because192
their milk production is decreased, as described below in sections 2.3.3 and 2.3.4.193
The model also includes an additional option to simulate a farmer who feeds194
only roughage without concentrate to cows that have their milk withdrawn due195
to antibiotic treatment, as described in Halasa et al. (2009a). For those cases,196
a proportion of the feed costs is subtracted to account for lower concentrate197
usage. By default, however, this option is disabled.198
2.3.2. Milking199
The daily milk yield is calculated for lactating cows (Kirkeby et al., 2016).200
However, differing from the iCull model, the income from milk is now dependent201
on the fat and protein content. Using the data set described in Kirkeby et al.202
(2016), we estimated the daily mean protein percentage for all cows, depending203
on days in milk (DIM) and parity (1, 2 and 3+), and fitted a three parameter204
Wood curve to each cow and parity in the data set (see Græsbøll et al., 2016).205
Based on the same data set, we estimated distributions for the fat to protein206
12
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ratio per parity. In the simulation model, each cow is assigned three parameters207
for the Wood curve to describe the protein percentage and, for each simulated208
day, the protein content is calculated based on the cow’s DIM. A fat to protein209
ratio is then drawn from the respective distribution for each cow and used to210
calculate the daily fat yield based on the milk yield and protein percentage.211
The income from milk is given by summing the income from fat and protein,212
withdrawing a milk handling fee based on the daily kg milk yield and multiplying213
with a penalty or bonus factor, depending on the bulk tank SCC (Table 3).214
2.3.3. Subclinical IMI215
Subclinically infected animals are subject to an increased SCC. For every216
subclinical quarter, an increase in the SCC is added to the generic simulated217
SCC, according to Schepers et al. (1997, Table 1) and Wilson et al. (1997,218
Table 2, used for scaling missing pathogens). If more than one quarter of a cow219
is subclinically infected, the maximum increase is added; however, the SCC is220
cut off at a maximum of 10, 000, 000 as higher SCC values are rarely observed221
and for numeric stabilization. The increased SCC in these subclinically infected222
animals also leads to a higher bulk tank SCC, which is calculated as the weighted223
mean SCC in the total daily amount of milk produced. The milk price, in turn,224
is dependent on the bulk tank SCC, as a bulk tank SCC up to 200, 000 will225
result in a 4% bonus, while a bulk tank SCC above 500, 000 will result in the226
maximal penalty of 10% (see Kirkeby et al., 2016).227
Linked to an increased SCC in subclinically infected cows is milk loss, and as228
the SCC varies daily for each cow, so does the milk loss. We used the estimates229
given in Hortet et al. (1999) to reduce the milk yield of each cow with at least230
one subclinical quarter according to SCC, DIM (except for primiparous cows)231
and parity (primiparous or multiparous, where we used the estimates for parity232
1 or 3+ cows, respectively), see supplementary Figure S7. The milk loss per233
cow is restricted to 2kg, which corresponds to the maximal loss in parity 3+234
within the limits of Hortet et al. (1999).235
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Parameter Value Description Reference
Antibiotic treat-
ment period
3 Number of days in antibiotic
treatment, milk from treated
cows is discarded.
Steeneveld et al. (2011)
Milk withdrawal
period
6 Number of days after antibiotic
treatment where the milk from
treated cows is discarded.
van den Borne et al.
(2010a), Michael Farre
pers. comm.
Acute mastitis
probability
0.01 Probability for a cow to get acute
mastitis, when it gets clinical
mastitis.
Michael Farre pers. comm.
Antibiotic treat-
ment cost
€33.3 Cost for antibiotic treatment of
one cow, not including vet visit
or farmer labor.
Michael Farre pers. comm.
Dry cow therapy
cost
€9.6 Cost for dry cow therapy for one
cow, which includes teat sealants
in 20% of the cases.
Michael Farre pers. comm.
Opportunity
costs
€20 Opportunity costs for treatment
of one cow with clinical mastitis.
Halasa et al. (2009a),
Michael Farre pers. comm.
Protein price €5.8132 Price for 1 kg protein www.arla.dk, September
2017
Fat price €4.1519 Price for 1 kg protein www.arla.dk, September
2017
Milk handling
fee
€0.0001343 Fee for handling 1 kg milk www.arla.dk, September
2017
Culling costs ca. €500 Costs for culling one cow (price
of a new heifer minus slaughter
value)
Huijps et al. (2008)
Table 3: Model parameters related to IMI treatment, culling, and milk price.
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2.3.4. Clinical IMI236
Clinical mastitis can reduce a cow’s milk production even after the cow is not237
clinical anymore (Gro¨hn et al., 2004). We used Gro¨hn et al. (2004) estimates for238
milk loss following clinical infection to fit logarithmic functions to the amount of239
milk lost for each pathogen type and for primiparous and multiparous cows. As240
a logarithmic function did not seem to be a suitable fit for primiparous cows with241
clinical IMI caused by Streptococcus spp., we fitted in this case a linear function242
truncated at zero (Figure S9). The respective milk loss is added throughout the243
whole lactation to the cow’s produced milk, starting on the first day of clinical244
infection. An example of the milk loss is given in Figure S8.245
When a cow gets a clinical IMI, it is treated. In the model, the default option246
comprises three days of antibiotic treatment, during which and for six days af-247
terwards the cow’s milk is withdrawn and discarded (Table 3). Treatment costs248
are based on expert opinion on Danish herds (see Table 3) and are comparable249
to the numbers given in Halasa et al. (2009a). They are divided into the costs250
of the antibiotics (€33.3) and opportunity costs (€20), which include the time251
the farmer has to spend on cows with clinical IMI (Table 3).252
2.3.5. Dry cow therapy253
Dry cow therapy is the treatment of cows with long lasting antibiotics at dry254
off. In the model, the default option applies antibiotic treatment only to cows255
that get a clinical IMI during the first week of dry off to study the dynamics256
of IMI without the influence of specific dry cow management. Other options257
include different selection strategies for selective dry cow therapy: cows with258
a history of clinical IMI, cows with a high SCC at the last monthly milk yield259
recording, cows with either of those options, and blanket dry cow therapy.260
2.3.6. Culling261
In the model, culling happens on a weekly basis. If there are more than262
200 lactating cows, the farmer will cull the excess number of cows. About263
half of the culled cows are chosen randomly, those are the cases that have to264
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be culled e.g. because of lameness. The others are chosen by the farmer from265
a culling list, where (s)he prioritizes the animals for culling, e.g. cows with266
production in the bottom 20%, with insemination difficulties, or with a high267
SCC at the last monthly milk yield recording, by applying weights for every268
unfavorable circumstance to each cow (Kirkeby et al., 2016). For every high269
SCC (> 200, 000) at subsequent monthly milk yield recordings, the respective270
cows will be increasingly prioritized, with a low SCC resetting this prioritization.271
After 12 months with a continuously high SCC, cows will be culled at the first272
possibility, though the default value of 12 months can be easily changed to reflect273
different management strategies.274
As subclinical IMI causes an increase in the SCC, cows with subclinical IMI275
have a higher probability to be prioritized for culling because of a high SCC.276
Cows with previous clinical IMI also have a higher probability of being chosen277
for culling than their herd mates. Bar et al. (2008a) found that the odds ratios278
for primiparous cows being culled were 7.46, 16.12 and 20.08, if they had 1, 2 or279
≥ 3 clinical mastitis cases, respectively (exponentiating values of Table 4 in Bar280
et al. (2008a)); for multiparous cows the respective odds ratios were 3.74, 5.00281
and 6.36. We used these values to apply weights to the culling decision made282
by the farmer, with multiparous cows with one previous clinical IMI receiving a283
weight of 1 and the other mentioned cases receiving weights scaled to reflect the284
ratios found in Bar et al. (2008a). Furthermore, it can happen, that a cow gets285
flagged for an acute IMI when it becomes clinical (Table 3). These cows will286
be put on top of the culling list, from which the farmer chooses in the weekly287
culling.288
Prioritization for culling is therefore: involuntary cases, cows with acute IMI,289
cows with a continuously high SCC, cows with the highest weight for culling.290
The costs of culled animals are calculated as the costs for raising a replace-291
ment heifer for each cow that is culled (to two years of age, €510), minus the292
slaughter value the farmer gets for the culled cow (€51).293
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2.3.7. Model outputs294
The epidemiological model output consists of daily cow level prevalences,295
as well as the total number of flare ups, remissions, subclinical, and clinical296
IMI for each simulation. Furthermore, it includes the total number of culled297
cows due to acute IMI, subclinical IMI and a history of clinical IMI. Culling298
due to subclinical IMI includes all culled cows with at least one subclinically299
infected quarter that were prioritized for culling because of a high SCC. To avoid300
counting a culled cow several times, culling due to the cow having a history of301
clinical IMI includes only cases in which the cow did not have a high SCC at302
the last monthly milk yield recording. Cows culled because of acute IMI are303
counted separately.304
The economical model output includes the total milk loss in kg due to sub-305
clinical or clinical IMI (both milk loss and withdrawal), as well as the total306
income from milk and the mean milk price penalty percentage (see sections307
2.3.2, 2.3.3, and 2.3.4). As the fat and protein percentages for lost milk are not308
calculated, a mean milk price of around €0.4099 per kg is used to calculate costs309
for milk loss (mean Arla milk price in September 2017). The mean milk price310
penalty value together with the total income from milk is used to calculate the311
possible penalty paid due to a high bulk tank SCC. Further economic output312
includes expenses for treatment of clinical IMI as described above (2.3.4), as313
well as costs for dry cow therapy (Table 3).314
2.4. Model validation315
Several methods for internal validation were used on the model (Sargent,316
2003). Rationalism, including operational graphics: various scenarios were com-317
pared to check consistency and credibility of model outputs. Traces: single cows318
were traced over time to check for consistency. Face validity: model assump-319
tions and outputs were evaluated by mastitis experts. External validation was320
conducted by comparing model predictions to the literature, as data to validate321
such a complicated model is not available.322
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2.4.1. Model convergence323
We tested model convergence on two parameters by simulating 1000 itera-324
tions. In a scenario without any IMI causing pathogens, we tested convergence325
of the energy corrected milk yield (ECM), and in a scenario with three pathogens326
(using default parameters taken from literature, see Table 1), we tested conver-327
gence on the number of clinical cases. In both cases visual inspection showed328
that 500 iterations were sufficient to obtain stable results (Figure S6). Further329
visual inspections showed that after five simulated years herd, population, and330
transmission dynamics were always stable, warranting a five year burn-in period.331
2.4.2. Sensitivity analysis and model runs332
We performed sensitivity analysis on a herd with 200 cows, using 500 sim-333
ulations of 5 years, with a burn-in time of an additional 5 years. All scenarios334
were initiated with a 20% starting prevalence for all pathogen strains, with the335
exception of environmental strains in multiple pathogen scenarios, where the336
starting prevalence was set to 10%. These values are arbitrary and were chosen337
only for presentation of the model.338
Sensitivity analyses were carried out on the transmission rate (β), the sponta-339
neous recovery probability, the probability that a newly infected animal becomes340
a clinical IMI case (Pc), the flare up probabilities, the environmental part of the341
opportunistic pathogen (ε), and the number of days the opportunistic pathogen342
can survive in the environment (d). For the transmission rate parameter, vari-343
ous scaling factors (all < 1, except for E. coli where factors > 1 were considered)344
were considered in the sensitivity analysis; selected values are presented in Ta-345
ble 4. Sensitivity analysis for the spontaneous recovery probability consisted of346
several scaling factors between 0.25 and 2. For the other parameters, sensitivity347
analyses focused on the actual value instead of the scaling factor: Pc and flare348
up probability were varied between 0.01 and 0.85 and between 0.0002 and 0.02,349
respectively. The parameter ε in opportunistic transmission was varied between350
0 and 1, while d was reduced down to 10 days in increments of 5 days.351
To obtain insight into how the model would simulate the dynamics of pathogen352
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spread, a great number of scenarios were run in the sensitivity analyses, of which353
only a few with different transmission rates were selected and presented here.354
In the supplementary material, more scenarios were included.355
3. Results356
Scenario Pathogens
Transmission rate
scaling factor Transmission rate
Transmission rate
(dry cows)
7 S. aureus 0.2 0.0036 0.0036
9 S. aureus 0.1 0.0018 0.0018
14 S. agalactiae 0.55 0.0037 0.0006
21 S. uberis (contagious) 0.8 0.0124 0.0009
49 S. aureus 0.25 0.0045 0.0045
S. agalactiae 0.5 0.0034 0.0006
56 S. aureus 0.25 0.0045 0.0045
S. uberis (contagious) 0.5 0.0078 0.0006
68 S. agalactiae 0.5 0.0034 0.0006
S. uberis (contagious) 0.5 0.0078 0.0006
88 S. uberis (contagious) 0.5 0.0078 0.0006
S. uberis (environmental) 0.01 0.0002 0.000 01
98 S. aureus 0.25 0.0045 0.0045
S. agalactiae 0.5 0.0034 0.0006
S. uberis (contagious) 0.5 0.0078 0.0006
S. uberis (environmental) 0.01 0.0002 0.000 01
E. coli 1 0.0001 0.0001
Table 4: Selected scenarios. All pathogens start with a 20% prevalence, except in the five
pathogen scenario (98), where the environmental strains start with a 10% prevalence. Trans-
mission rates are rounded.
Figure 2: Cow level prevalences in one pathogen scenarios 7, 9, 14, and 21, see Table 4. Every
scenario shows smoothed daily prevalences for each of 500 iterations over 5 years with a 5
year burn-in period (with one random iteration displayed in gray), as well as the mean daily
prevalence (bold, black). The bottom lines show the daily prevalences of clinical IMI, with
the mean displayed as a dashed line.
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Figure 3: Cow level prevalences in two pathogen scenarios 49, 56, 68, and 88, see Table 4.
Every scenario shows smoothed daily prevalences for each of 500 iterations over 5 years after
a 5 year burn-in period (with one random iteration displayed in gray), as well as the mean
daily prevalence (bold, black). The bottom lines show the daily prevalences of clinical IMI,
with the mean displayed as a dashed line.
Figure 4: Cow level prevalences in the five pathogen scenario see Table 4, scenario 98. It shows
the smoothed daily prevalences for each of 500 iterations over 5 years after a 5 year burn-in
period (with one random iteration displayed in gray), as well as the mean daily prevalence
(bold, black). The bottom lines show the daily prevalences of clinical IMI, with the mean
displayed as a dashed line.
The methods used for internal validation showed valid and consistent out-357
comes of the model in all scenarios. As an illustration, nine scenarios were358
selected. These include four one pathogen scenarios for different pathogens,359
four two pathogen scenarios with different pathogen combinations, and one five360
pathogen scenario with all pathogens (Table 4). Scenarios where exact liter-361
ature values were used as transmission parameters, led to high prevalences in362
our setting (results not shown). Therefore, the selected scenarios used adjusted363
transmission rates, leading to more realistic prevalence estimates (Figures 2, 3,364
and 4).365
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Figure 2 shows selected scenarios with one active pathogen. The starting366
prevalence is set to 20%, and during the burn-in period it fluctuates depending367
on the pathogen strain (i.e. the combination of all transmission parameters, see368
scenarios 7, 14, and 21, Figure 2), or changes depending on the transmission369
rate (scenarios 9 and 7, Figure 2). After the burn-in period, the prevalence has370
reached a mostly stable level.371
The model also allows coexistence of multiple pathogens or strains, regardless372
of their transmission mode, on different prevalence levels, depending on the373
scaling of the transmission parameters (Figures 3 and 4). Scenario 49 and 56374
show two pathogen scenarios, where the active pathogen strains are S. aureus375
and S. agalactiae or a contagious S. uberis, respectively. The transmission rate376
for S. aureus is the same in both scenarios, however the mean daily prevalence is377
higher in scenario 56, where the second active pathogen is present at a low level.378
In scenario 68, S. agalactiae and the contagious S. uberis strain are coexisting at379
similar levels to scenario 49 and 56, respectively. Scenario 88 (Figure 3) shows380
another scenario with two active pathogen strains, in this case a contagious381
and an environmental strain of S. uberis. Both strains are present at a similar382
prevalence, with a higher variation for the contagious strain.383
Scenario 98 shows a five pathogen, which also includes both a contagious384
and an environmental strain of S. uberis together with contagious S. aureus,385
environmental E. coli, and opportunistic S. agalactiae (Figure 4). The conta-386
gious strains have the same transmission rate as in the two pathogen scenarios387
and are at similar daily prevalence levels. The opportunistic S. agalactiae strain388
also has the same transmission rate as in the two pathogen scenarios, but the389
prevalence level has increased.390
The epidemiological output in Table 5 shows the number of quarter cases391
per year (median over 500 iterations and mean over 5 years simulation period);392
in the multiple pathogen scenarios, numbers are summed over all pathogens.393
The number of subclinical IMI includes all remission cases, while the number of394
clinical IMI includes all flare up cases. Also, one cow may be counted more than395
one time for the same infection, e.g. if a clinical quarter went into remission and396
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Scenario Flare up Remission subclinical IMI clinical IMI
7 120 (101, 140) 113 (95, 134) 258 (228, 293) 134 (113, 157)
9 44 (36, 53) 40 (32, 48) 98 (84, 112) 47 (38, 57)
14 7 (4, 10) 4 (2, 6) 77 (51, 107) 8 (5, 12)
21 78 (57, 114) 72 (49, 110) 244 (174, 363) 149 (105, 225)
49 172 (147, 200) 164 (138, 192) 436 (385, 498) 196 (167, 227)
56 221 (197, 257) 209 (186, 247) 482 (437, 551) 264 (237, 306)
68 33 (27, 40) 22 (17, 28) 139 (112, 171) 46 (38, 56)
88 58 (50, 67) 45 (37, 53) 136 (120, 156) 94 (82, 108)
98 261 (232, 294) 250 (221, 284) 693 (640, 752) 370 (333, 410)
Table 5: Epidemiological output in median number (with 5% and 95% percentiles) of quarter
cases per year (mean over 5 years) of the scenarios in Table 4. Numbers are rounded.
Scenario high SCC acute IMI history of IMI
7 22 (18, 26) 1 (0, 2) 3 (2, 4)
9 13 (10, 16) 0 (0, 1) 2 (1, 3)
14 24 (19, 29) 0 (0, 0) 0 (0, 1)
21 15 (10, 20) 1 (0, 2) 4 (3, 6)
49 48 (41, 55) 1 (1, 2) 2 (1, 3)
56 35 (30, 39) 2 (1, 3) 3 (2, 4)
68 27 (21, 33) 0 (0, 1) 2 (1, 3)
88 10 (7, 13) 1 (0, 1) 5 (3, 6)
98 68 (60, 76) 2 (1, 3) 2 (1, 4)
Table 6: Median number (with 5% and 95% percentiles) of culled cases per year (mean over
5 years) of the scenarios in Table 4, see section 2.3.6 for culling categories. Numbers are
rounded.
flared up again afterwards. For S. agalactiae, most clinical IMI are flared up397
subclinical cases and there are few clinical IMI, if the prevalence is at moderate398
levels (scenario 14). In contrast, the contagious S. uberis strain leads to many399
more clinical cases, both flared up and directly infected (scenario 21).400
Table 6 shows the number of culled cows per year (median over 500 iterations401
and mean over 5 years simulation period); acutely culled cows, subclinical cows402
that were culled with a noticeable high SCC, and culled cows with a history403
of clinical IMI. Most cows that are culled because of IMI related reasons are404
connected to a high SCC, though the number and proportion of cows culled405
with subclinical IMI or a history of clinical IMI also depends on the causative406
pathogen.407
The costs associated with subclinical and clinical IMI can be found in the408
supplementary Tables S1, S2, and S3.409
22
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Further sensitivity analyses showed that the probability of spontaneous re-410
covery for subclinical cases is similarly influential on the prevalence as the trans-411
mission rate (Figure S1): with a higher probability of spontaneous recovery, the412
prevalence decreases.413
Sensitivity analysis for the probability for a newly infected quarter to be414
clinical (Pc, Table 1) showed that for S. agalactiae and the contagious strain of S.415
uberis an increased proportion of clinical cases leads to a decreased prevalence,416
while this effect was less observable in the environmental pathogens and S.417
aureus (Figure S2). Similarly, the higher the flare up probability is, the lower418
the prevalence becomes (Figure S3).419
If the environmental part ε in the opportunistic infection is increased, the420
prevalence increases, too, ranging from a mean of 17.8% with pure contagious421
infection (ε = 0) to a mean of 30.3 without any contagious part (ε = 1) after422
10 years. This effect is not visible, if the prevalence is low (< 5%, Figure S4).423
Reducing the number of days d the opportunistic pathogen can survive in424
the environment showed marginal effects on model outcome, which is expected425
due to how the bacterial survival is weighted.426
4. Discussion427
The described model simulates a dairy cattle herd on daily basis, including428
the spread of IMI causing pathogens within the herd. It also includes various429
treatment variants for IMI, that will be investigated for cost-effectiveness in430
following studies. The aim of this study was to describe the model, includ-431
ing a new opportunistic transmission mode. With the historical view of purely432
contagious and purely environmental pathogens being questioned (e.g., Zadoks433
et al., 2001a; Jorgensen et al., 2016), we think that this feature is an important434
step in modelling IMI spread, representing both the possibility of strain spe-435
cific transmission properties and recent suggestions of S. agalactiae’s potential436
opportunistic behaviour. The opportunistic transmission mode combines both437
contagious (via milking) and environmental transmission in one strain, as indi-438
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cated by Jorgensen et al. (2016). The contagious part of this new feature was439
transferred from previously already implemented contagious transmission (Ha-440
lasa et al., 2009a). The environmental part represents the decay of the pathogen441
in the environment over time. Using an exponential function to represent the442
decay of infectious agents in the environment is not unusual, although slope443
of decline may differ for different pathogens (e.g., Whiting et al., 1996; Halasa444
et al., 2016). Still, implementing it for S. agalactiae should be acceptable. The445
infection probability depends on three main elements, in addition to the ba-446
sic transmission rate; the contribution of the environment, the slope of decay,447
and the duration of pathogen survival in the environment. The latter has been448
approximated based on literature (Jorgensen et al., 2016), but the two other449
elements are lacking actual data from the field. We speculate that the impact of450
the environmental part is strain-specific, meaning that some strains are mainly451
found in the environment, persisting there for some time and causing new infec-452
tions, while others mainly spread via the contagious route. The weight of each453
mechanism is unknown, which warrants further research to assess the influence454
of the environment on the spread of this pathogen. Our model allows weighting455
of the contagious and environmental parts of pathogen spread, depending on,456
e.g., the strain type. Our current parameterization (ε = 0.1) would represent a457
mainly contagious spread of the pathogen with occasional transmission of IMI458
through the environment. This was done as an illustration of opportunistic459
spread in the model. In the future, the effect of the different parameters must460
be examined properly, when simulating the impact of control strategies against461
IMI caused by S. agalactiae.462
Default values for all transmission parameters were taken from literature463
(Tables 1 and 2), which led to unrealistically high prevalences (Figures 2, 3,464
and 4). This is not surprising, as studies are usually conducted in herds with465
large problems or even outbreaks with the specific pathogens. In those herds,466
pathogen spread, and thereby the calculated transmission rates, are high. On467
top of that, our additional susceptibility factor Suscq, used to re-scale the trans-468
mission rates to include cow-specific infection, leads to higher infection proba-469
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bilities in the model. The estimated transmission rates from the literature do470
not consider quarter factors, but instead they are average values for all quar-471
ters. For instance, it is known that the risk of infection is higher for quarters472
with previous IMI (Zadoks et al., 2001b). In order to consider the effect of473
these factors in the estimation of infection probability, the transmission rates474
are multiplied by the relative risks of quarter factors (the susceptibility factor),475
and hence the probability becomes artificially higher than normal. To represent476
a realistic situation, it therefore becomes important to rescale the transmission477
rates, as the quarter factors should be taken into account at the same time.478
Future studies estimating transmission rates should consider the effects of quar-479
ter and cow factors on the transmission rate, if possible, in order to be able to480
accurately model spread dynamics of IMI causing pathogens.481
Our results show sensitivity of the prevalence to changes in transmission rate482
and other transmission parameters (see Figures S1–S4), making the use of the483
right parameters important. It is therefore worrisome that estimates of trans-484
mission rates are scarce and limited to few studies from few herds (e.g., Zadoks485
et al., 2001a, 2003; Barlow et al., 2013; Leelahapongsathon et al., 2016). Nev-486
ertheless, we decided to include a susceptibility factor and thereby cow-specific487
transmission in the model and adjust transmission, as studies have shown that488
relevant risk factors exist (e.g., Zadoks et al., 2001b). As these factors may be489
pertinent for management decisions regarding IMI, not including them would490
prevent investigating cow-specific management strategies in the future. Further-491
more, as IMI causing pathogens are thought to be transmitted, among other492
things, during the milking process (Harmon, 1994) or through reservoirs in the493
environment (Zadoks et al., 2001a; Blowey and Edmondson, 2010), transmis-494
sion rates are dependent on herd related factors. Considering that there are495
only few studies estimating these rates, and conditions are prone to change over496
the years, transmission rates, in the absence of proper data, will have to be497
adjusted in some way to model different IMI situations representing different498
herds or management systems. Hopefully, future research can close these gaps.499
Another point regarding transmission is the assumption in the model that500
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the same transmission rate can be used for transmission to quarters of the same501
cow or of other cows. When transmission happens through the milking equip-502
ment, for instance, fluctuations in the milking vacuum could, depending on503
the milking machine’s claw, lead to a reflux of milk from an infected quarter504
into uninfected teats (Besier et al., 2016). IMI can also be transmitted by flies505
(Owens et al., 1998). A fly would probably land on a quarter of the same cow506
before flying away, possibly leading to a higher risk of within cow spread. Given507
the absence of proper data to parameterize this process, the made assumption508
seems inevitable. Should this knowledge gap be closed in the future, differ-509
ent transmission probabilities could be used for within cow and between cow510
transmission.511
Our results showed expected behavior when parameters were changed in512
sensitivity analyses. Different scenarios showed different prevalence patterns,513
e.g., in scenarios 49 and 56 (Figure 3), where the prevalence of S. aureus was514
higher when the second pathogen’s prevalence was lower. In scenario 98 (Figure515
4), S. agalactiae reached a higher prevalence level than in scenarios 49 or 68516
(Figure 3), even though the transmission rate was the same, showing a different517
behavior of opportunistic transmission depending on the prevalence of other518
IMI pathogens. An increased total prevalence leads to more quarters having a519
higher risk of contracting an IMI, as history of IMI is modelled as a risk factor520
for new IMI. This, combined with the fact that S. agalactiae can build up and521
persist in the environment, leads to its increased incidence. The model can522
thus simulate different transmission behaviors of pathogens and different herds,523
which is necessary to investigate, e.g., how effective a treatment regimen is under524
different circumstances. The economic part of the model yields comparable525
results to other models. For instance, Steeneveld et al. (2007) found an average526
per case cost of €109 for subclinical IMI, while our scenario 9 resulted in a527
median cost of about €100 per subclinical IMI case S1. In the same scenario,528
the median cost for a clinical IMI case was around €226, which is similar to529
other studies by e.g. Halasa et al. (2009a) (€101 to €328), Huijps et al. (2008)530
(€164 to €235), and Bar et al. (2008b) (€179 on average). As a substantial531
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part of the costs for IMI arises from culling (Tables S1 and S2), and farmers532
behave differently in terms of culling (e.g., Fetrow et al., 2006), modelling herd-533
specific scenarios instead of average herds is also important for cost-effectiveness534
analyses.535
Altogether, our model is able to simulate strain-, cow-, and herd-specific536
transmission of IMI causing pathogens on quarter level and with a daily time537
step. It also includes the possibility to consider different farmer priorities con-538
cerning culling by changing culling weights, or to include a prediction of the539
future value of a cow relative to its herd mates (Græsbøll et al., 2017) in the540
culling decision of the farmer, allowing a potentially more economic choice of541
cows to be culled. Moreover, the necessary features to study several treatment542
strategies for clinical IMI and selection strategies for dry cow therapy are al-543
ready implemented in the model, and further strategies or pathogen strains544
can be easily added. This makes it possible to simulate specific herds and in-545
vestigate the cost-effectiveness of various changes to management/prevention or546
treatment/control strategies, both short term (operational decision making) and547
long term (strategic decision making), that can also be strain- and cow-specific.548
As different changes may be more cost-effective depending on the herd, and se-549
lective treatment decisions may be more effective when selecting the right cows550
to treat, it is important to include strain-, cow-, and herd-specifics in a model in-551
vestigating cost-effective strategies. Simulating specific instead of average herds552
also means simulating diverse herd-specific disease situations, that are repre-553
sented by different combinations of pathogens at different (stable) prevalence554
levels, which is possible with this model as shown in Figures 3 and 4.555
Other bio-economic models simulating mastitis and mastitis control already556
exist, but to our knowledge none of the existing models combine all features557
presented in this model. The model by Halasa et al. (2009a, 2010) used the558
same transmission framework on cow instead of quarter level, but without in-559
cluding cow-specific infection and recovery. By simulating on quarter level, we560
allow multiple infections per cow, as this happens in reality, though one quarter561
can still only be infected by one pathogen or strain in our model. With this, our562
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model also differs from e.g. the SIMMAST model (Allore et al., 1998), which also563
simulates on cow level, though it does not include cow-specific recovery, and only564
allows infection with one pathogen at a time. The SimHerd model (Østergaard565
et al., 2005) allows several pathogens per cow and is cow- and herd-specific,566
however, cow-specific factors are only considered for infection. SimHerd’s mas-567
titis framework is based on weekly time steps and infection through a baseline568
risk function for all mastitis pathogens. While this is a valid approach in the569
setting Østergaard et al. (2005) investigated, our model can explore both con-570
stant spread and infection over time, as well as transitions between the two. In571
addition, modelling on quarter level is closer to the underlying biology, as IMI572
occurs on quarter level. By modelling the actual biological unit, IMI manage-573
ment can also be modelled on quarter level, e.g. drying off chronically infected574
quarters.575
While previous models may distinguish between contagious and environ-576
mental spread, our model explicitly allows both contagious and environmental577
strains of the same pathogen, exemplified by S. uberis, and also introduces a578
new third opportunistic transmission type with both contagious and environ-579
mental properties, as discussed above. Furthermore, while we only included S.580
uberis with an environmental and a contagious strain to illustrate the possibility581
of having two strains with different transmission modes, this option should be582
kept in mind regarding other pathogens like e.g. S. aureus, as the model allows583
easy addition of other pathogens or pathogen strains. The question of which584
type of transmission is the right one for a particular pathogen strain cannot585
be answered by models, but our model allows the user to choose between the586
three mentioned transmission types and compare e.g. management strategies,587
depending on what kind of transmission is assumed for a strain. This allows588
investigations into cost-effectiveness of various strain-, cow-, and herd-specific589
IMI prevention and control measures, while including a farmer’s current strate-590
gies, thereby hopefully making it easier to convince farmers to adopt proposed591
cost-effective changes in the future.592
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5. Conclusions593
We developed a strain-, cow-, and herd-specific bio-economic simulation594
model of IMI and introduced a new opportunistic transmission mode. The595
model is sensitive to parameter changes in the transmission framework, but596
it can be fitted to simulate various pathogen scenarios, representing different597
herd situations. However, we found that available parameter estimations for598
IMI transmission or cure may be becoming outdated and we therefore suggest599
future studies to investigate new parameter estimations. The economic output600
allows cost estimations of both subclinical and clinical IMI, which lie within the601
ranges found in earlier studies. This makes it possible to use the model in future602
studies to investigate cost-effective prevention and control measures against IMI603
that are tailored to a specific herd, hopefully making it easier to convince the604
farmer to adopt proposed changes.605
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